Exploratory clinical study on effects to the blood flow and safety of transcutaneous application of carbon dioxide for fractured limbs - Investigation of effects of transcutaneous application of carbon dioxide to fractured limbs

Kobe University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2014年7月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

ineteen patients were subjected to complete analysis. No adverse events were observed. Arterial and expired gas analyses revealed no adverse systemic effects including hypercapnia. The mean ratio of blood flow 20 min after CO2 therapy compared with the pre-treatment level increased by approximately 2-fold in a time-dependent manner.

研究设计

研究类型: Interventional

入排标准

年龄范围: 15years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•Pathological fracture Peripheral artery disease or ischemia in the fractured limb Skin disease in the fractured limb Infection in the fractured limb Inadequate condition both general and local No written informed consent Patients who are judged as contraindication with any reasons by the doctors in charge

研究者

发起方

Kobe University Graduate School of Medicine

相似试验

已完成

不适用

Changes of flow in Arterial anastomosis of Free flap after the Intraoperative administration of AlprostadilDiseases of the skin and subcutaneous tissue

KCT0002166Asan Medical Center44

尚未招募

Unknown

Change in blood parameters after treatment in Children with Attention Deficit/Hyperactivity Disorder.

CTRI/2023/11/059629Governement Medical College and Hospital

已完成

不适用

A confirmation study of the influence for blood vessel by consumption of test foodHealthy adults

JPRN-UMIN000036448CPCC Company Limited24

进行中（未招募）

不适用

Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonary

EUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40

已完成

不适用

A clinical study on the correlation between blood glucose level and glucose concentration in aqueous humor of cataract surgery patientsCataract

JPRN-UMIN000017362Department of Ophthalmology, Keio University School of Medicine10